利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

2031 条记录 (耗时 0.057 秒)

    MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF
    61.
    发明申请
    MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF 审中-公开

    公开(公告)号：US20190077783A1

    公开(公告)日：2019-03-14

    申请号：US16181503

    申请日：2018-11-06

    申请人： SYMRISE AG

    发明人： Oskar KOCH ,  Marcus Rudolf GÖTZ

    IPC分类号： C07D311/80 ,  C07C37/50 ,  C07C69/94 ,  A61K31/235 ,  A61K31/352 ,  C07C39/23 ,  C07C67/03 ,  C07C67/343

    摘要： Described are specific mixtures comprising one or more (cannabinoid) compounds of the formula (A) and/or one or more of their salts as well was methods for their production. Further described are a compound of the formula (A), a salt of the formula (A) and a corresponding mixture for use as a medicament or, respectively, for use in a method for therapeutic treatment of the human or animal body.Described are also corresponding pharmaceutical formulations, cosmetic preparations and preparations for pleasure and/or nutrition, suitable for consumption, as well as methods for producing CBDV and THCV.

    VIVO INTRACELLULAR REPROGRAMMING COMPOSITION AND METHOD OF MAKING AND USING SAME
    69.
    发明申请
    VIVO INTRACELLULAR REPROGRAMMING COMPOSITION AND METHOD OF MAKING AND USING SAME 审中-公开

    公开(公告)号：US20180207113A1

    公开(公告)日：2018-07-26

    申请号：US15416207

    申请日：2017-01-26

    申请人： Vincent C Giampapa

    发明人： Vincent C Giampapa

    IPC分类号： A61K31/155 ,  A61K31/235 ,  A61K36/74 ,  A61K36/906 ,  A61K31/12 ,  A61K9/00 ,  A61K47/06 ,  A23L33/10

    CPC分类号： A61K31/155 ,  A23L33/10 ,  A61K31/12 ,  A61K31/235 ,  A61K36/74

    摘要： An in vivo intracellular reprogramming method for both somatic and stem cell pools in the mammal's body using, C60 fullerenes can be added to enhance mitochondrial ATP production and Biogenesis, Metformin, Everolimus, Seligilene, Danasitab, Venetoclaxalong with Quercitin may act as agent to enhance autophagy and apoptosis helping to decrease their ongoing formation and a novel resveratrol complex along ribonucleasies worth together to help decrease heterchromation dysregulation aid in DNA repair enhancement and nutraceuticals is disclosed. The present in vivo reprogramming invention works at the epigenetic level and promotor region of the genome inside the nucleus of the cell, and other intracellular organelles, rather than outside the body. The key genetic activity changes that the invention reverses have now been found responsible for causing aging in adult stem cells and somatic cells, the combination of the above compounds have been shown to cause improved and corrected epigenetic changes or reprogramming in vivo in gene expression to induce the necessary genetic changes to improve cellular aging and epigenetic IC changes responsible for the changes and therefore effect total body and cellular health from the organ and tissue level on upward. The key to and extended to a long and healthy life is keeping your somatic cells health and maintaining a pool of stem cells can be called on for acute situations like healing form surgery or trauma or an immune boast to frequent infection.